data_1O6N # _entry.id 1O6N # _audit_conform.dict_name mmcif_pdbx.dic _audit_conform.dict_version 5.280 _audit_conform.dict_location http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic # loop_ _database_2.database_id _database_2.database_code PDB 1O6N PDBE EBI-11499 WWPDB D_1290011499 # _pdbx_database_PDB_obs_spr.id OBSLTE _pdbx_database_PDB_obs_spr.date 2005-04-21 _pdbx_database_PDB_obs_spr.pdb_id 2BP4 _pdbx_database_PDB_obs_spr.replace_pdb_id 1O6N _pdbx_database_PDB_obs_spr.details ? # loop_ _pdbx_database_related.db_name _pdbx_database_related.db_id _pdbx_database_related.content_type _pdbx_database_related.details PDB 1AAP unspecified . PDB 1AMB unspecified ;ALZHEIMER'S DISEASE AMYLOID BETA-PEPTIDE (RESIDUES 1 - 28) (NMR, MINIMIZED AVERAGE STRUCTURE) ; PDB 1AMC unspecified ;ALZHEIMER'S DISEASE AMYLOID BETA-PEPTIDE (RESIDUES 1 - 28) (NMR, 5 STRUCTURES) ; PDB 1AML unspecified 'THE ALZHEIMER`S DISEASE AMYLOID A4 PEPTIDE (RESIDUES 1-40)' PDB 1BA4 unspecified ;THE SOLUTION STRUCTURE OF AMYLOID BETA- PEPTIDE (1-40) IN A WATER-MICELLE ENVIRONMENT. IS THE MEMBRANE-SPANNING DOMAIN WHERE WE THINK IT IS? NMR, 10 STRUCTURES ; PDB 1BA6 unspecified ;SOLUTION STRUCTURE OF THE METHIONINE-OXIDIZED AMYLOID BETA-PEPTIDE (1-40). DOES OXIDATION AFFECT CONFORMATIONAL SWITCHING? NMR,10 STRUCTURES ; PDB 1BJB unspecified 'SOLUTION NMR STRUCTURE OF AMYLOID BETA[E16], RESIDUES 1-28, 14 STRUCTURES' PDB 1BJC unspecified 'SOLUTION NMR STRUCTURE OF AMYLOID BETA[F16], RESIDUES 1-28, 15 STRUCTURES' PDB 1BRC unspecified . PDB 1CA0 unspecified 'BOVINE CHYMOTRYPSIN COMPLEXED TO APPI' PDB 1MWP unspecified 'N-TERMINAL DOMAIN OF THE AMYLOID PRECURSOR ROTEIN' PDB 1QCM unspecified 'AMYLOID BETA PEPTIDE (25-35), NMR, 20 STRUCTURES' PDB 1TAW unspecified 'BOVINE TRYPSIN COMPLEXED TO APPI' # _pdbx_database_status.status_code OBS _pdbx_database_status.entry_id 1O6N _pdbx_database_status.deposit_site PDBE _pdbx_database_status.process_site PDBE _pdbx_database_status.SG_entry . _pdbx_database_status.status_code_sf ? _pdbx_database_status.status_code_mr ? _pdbx_database_status.status_code_cs ? _pdbx_database_status.recvd_initial_deposition_date 2002-10-08 _pdbx_database_status.pdb_format_compatible Y _pdbx_database_status.methods_development_category ? # loop_ _audit_author.name _audit_author.pdbx_ordinal 'Zirah, S.' 1 'Blond, A.' 2 'Cheminant, M.' 3 'Kozin, S.' 4 'Segalas-Milazzo, I.' 5 'Debey, P.' 6 'Rebuffat, S.' 7 # _citation.id primary _citation.title ;Role of the 1-16 N-Terminal Region in the Transconformation Involved in Alzheimer'S Disease ; _citation.journal_abbrev 'To be Published' _citation.journal_volume ? _citation.page_first ? _citation.page_last ? _citation.year ? _citation.journal_id_ASTM ? _citation.country ? _citation.journal_id_ISSN ? _citation.journal_id_CSD 0353 _citation.book_publisher ? _citation.pdbx_database_id_PubMed ? _citation.pdbx_database_id_DOI ? # loop_ _citation_author.citation_id _citation_author.name _citation_author.ordinal primary 'Zirah, S.' 1 primary 'Kozin, S.A.' 2 primary 'Blond, A.' 3 primary 'Cheminant, M.' 4 primary 'Debey, P.' 5 primary 'Rebuffat, S.' 6 # _cell.entry_id 1O6N _cell.length_a 1.000 _cell.length_b 1.000 _cell.length_c 1.000 _cell.angle_alpha 90.00 _cell.angle_beta 90.00 _cell.angle_gamma 90.00 _cell.Z_PDB 1 _cell.pdbx_unique_axis ? # _symmetry.entry_id 1O6N _symmetry.space_group_name_H-M 'P 1' _symmetry.pdbx_full_space_group_name_H-M ? _symmetry.cell_setting ? _symmetry.Int_Tables_number 1 # _entity.id 1 _entity.type polymer _entity.src_method syn _entity.pdbx_description ;ALZHEIMER'S DISEASE AMYLOID A4 PROTEIN ; _entity.formula_weight 1960.047 _entity.pdbx_number_of_molecules 1 _entity.pdbx_ec ? _entity.pdbx_mutation ? _entity.pdbx_fragment 'RESIDUES 672-687' _entity.details ? # _entity_name_com.entity_id 1 _entity_name_com.name 'PROTEASE NEXIN-II, PN-II, APPI, BETA-AMYLOID PROTEIN, BETA-APP, A-BETA' # _entity_poly.entity_id 1 _entity_poly.type 'polypeptide(L)' _entity_poly.nstd_linkage no _entity_poly.nstd_monomer no _entity_poly.pdbx_seq_one_letter_code DAEFRHDSGYEVHHQK _entity_poly.pdbx_seq_one_letter_code_can DAEFRHDSGYEVHHQK _entity_poly.pdbx_strand_id A _entity_poly.pdbx_target_identifier ? # loop_ _entity_poly_seq.entity_id _entity_poly_seq.num _entity_poly_seq.mon_id _entity_poly_seq.hetero 1 1 ASP n 1 2 ALA n 1 3 GLU n 1 4 PHE n 1 5 ARG n 1 6 HIS n 1 7 ASP n 1 8 SER n 1 9 GLY n 1 10 TYR n 1 11 GLU n 1 12 VAL n 1 13 HIS n 1 14 HIS n 1 15 GLN n 1 16 LYS n # _pdbx_entity_src_syn.entity_id 1 _pdbx_entity_src_syn.pdbx_src_id 1 _pdbx_entity_src_syn.pdbx_alt_source_flag sample _pdbx_entity_src_syn.pdbx_beg_seq_num ? _pdbx_entity_src_syn.pdbx_end_seq_num ? _pdbx_entity_src_syn.organism_scientific 'HOMO SAPIENS' _pdbx_entity_src_syn.organism_common_name HUMAN _pdbx_entity_src_syn.ncbi_taxonomy_id ? _pdbx_entity_src_syn.details ? # _struct_ref.id 1 _struct_ref.db_name UNP _struct_ref.db_code A4_HUMAN _struct_ref.entity_id 1 _struct_ref.pdbx_seq_one_letter_code ? _struct_ref.pdbx_align_begin ? _struct_ref.pdbx_db_accession P05067 _struct_ref.pdbx_db_isoform ? # _struct_ref_seq.align_id 1 _struct_ref_seq.ref_id 1 _struct_ref_seq.pdbx_PDB_id_code 1O6N _struct_ref_seq.pdbx_strand_id A _struct_ref_seq.seq_align_beg 1 _struct_ref_seq.pdbx_seq_align_beg_ins_code ? _struct_ref_seq.seq_align_end 16 _struct_ref_seq.pdbx_seq_align_end_ins_code ? _struct_ref_seq.pdbx_db_accession P05067 _struct_ref_seq.db_align_beg 672 _struct_ref_seq.pdbx_db_align_beg_ins_code ? _struct_ref_seq.db_align_end 687 _struct_ref_seq.pdbx_db_align_end_ins_code ? _struct_ref_seq.pdbx_auth_seq_align_beg 1 _struct_ref_seq.pdbx_auth_seq_align_end 16 # loop_ _chem_comp.id _chem_comp.type _chem_comp.mon_nstd_flag _chem_comp.name _chem_comp.pdbx_synonyms _chem_comp.formula _chem_comp.formula_weight ALA 'L-peptide linking' y ALANINE ? 'C3 H7 N O2' 89.093 ARG 'L-peptide linking' y ARGININE ? 'C6 H15 N4 O2 1' 175.209 ASP 'L-peptide linking' y 'ASPARTIC ACID' ? 'C4 H7 N O4' 133.103 GLN 'L-peptide linking' y GLUTAMINE ? 'C5 H10 N2 O3' 146.144 GLU 'L-peptide linking' y 'GLUTAMIC ACID' ? 'C5 H9 N O4' 147.129 GLY 'peptide linking' y GLYCINE ? 'C2 H5 N O2' 75.067 HIS 'L-peptide linking' y HISTIDINE ? 'C6 H10 N3 O2 1' 156.162 LYS 'L-peptide linking' y LYSINE ? 'C6 H15 N2 O2 1' 147.195 PHE 'L-peptide linking' y PHENYLALANINE ? 'C9 H11 N O2' 165.189 SER 'L-peptide linking' y SERINE ? 'C3 H7 N O3' 105.093 TYR 'L-peptide linking' y TYROSINE ? 'C9 H11 N O3' 181.189 VAL 'L-peptide linking' y VALINE ? 'C5 H11 N O2' 117.146 # loop_ _pdbx_nmr_exptl.experiment_id _pdbx_nmr_exptl.conditions_id _pdbx_nmr_exptl.type _pdbx_nmr_exptl.solution_id 1 1 COSY-DQF 1 2 1 TOCSY 1 3 1 NOESY 1 4 1 HSQC 1 5 1 HMBC 1 # _pdbx_nmr_exptl_sample_conditions.conditions_id 1 _pdbx_nmr_exptl_sample_conditions.temperature 298 _pdbx_nmr_exptl_sample_conditions.pressure_units ? _pdbx_nmr_exptl_sample_conditions.pressure ? _pdbx_nmr_exptl_sample_conditions.pH 3.0 _pdbx_nmr_exptl_sample_conditions.ionic_strength ? _pdbx_nmr_exptl_sample_conditions.ionic_strength_units ? _pdbx_nmr_exptl_sample_conditions.pH_units pH _pdbx_nmr_exptl_sample_conditions.temperature_units K # _pdbx_nmr_spectrometer.spectrometer_id 1 _pdbx_nmr_spectrometer.model 'AVANCE400, DMX600' _pdbx_nmr_spectrometer.manufacturer Bruker _pdbx_nmr_spectrometer.field_strength 400 # _pdbx_nmr_refine.entry_id 1O6N _pdbx_nmr_refine.method 'simulated annealing' _pdbx_nmr_refine.details ;INPUT DATA USED FOR STRUCTURE CALCULATION CONSIST IN 162 UPPER AND LOWER DISTANCE RESTRAINTS AND 9 AMBIGUOUS RESTRAINTSFROM NOE DATA (NOESY 100MS) AND 11 PHI DIHEDRAL ANGLE RESTRAINTS ; _pdbx_nmr_refine.software_ordinal 1 # _pdbx_nmr_ensemble.entry_id 1O6N _pdbx_nmr_ensemble.conformers_calculated_total_number 100 _pdbx_nmr_ensemble.conformers_submitted_total_number 30 _pdbx_nmr_ensemble.conformer_selection_criteria 'LEAST RESTRAINT VIOLATION, ALLOWED REGIONS IN RAMACHANDRAN PLOT' # _pdbx_nmr_representative.entry_id 1O6N _pdbx_nmr_representative.conformer_id 8 _pdbx_nmr_representative.selection_criteria ? # loop_ _pdbx_nmr_software.classification _pdbx_nmr_software.name _pdbx_nmr_software.version _pdbx_nmr_software.authors _pdbx_nmr_software.ordinal refinement X-PLOR3.1 ? ? 1 'structure solution' 'BRUKER X-WIN NMR' NMR ? 2 'structure solution' 'BRUKER AURELIA' AURELIA ? 3 'structure solution' X-PLOR ? ? 4 # _exptl.entry_id 1O6N _exptl.method 'SOLUTION NMR' _exptl.crystals_number ? # _struct.entry_id 1O6N _struct.title '(1-16) FRAGMENT OF THE BETA-AMYLOID PROTEIN (BETA-APP40,BETA-APP42) IN TFE/WATER 80/20 SOLUTION' _struct.pdbx_descriptor ;ALZHEIMER'S DISEASE AMYLOID A4 PROTEIN ; _struct.pdbx_model_details ? _struct.pdbx_CASP_flag ? _struct.pdbx_model_type_details ? # _struct_keywords.entry_id 1O6N _struct_keywords.pdbx_keywords 'GLYCOPROTEIN/AMYLOID PEPTIDE' _struct_keywords.text ;ALZHEIMER'S DISEASE, AMYLOID PEPTIDE, BETA-AMYLOID PROTEIN, GLYCOPROTEIN-AMYLOID PEPTIDE complex ; # _struct_asym.id A _struct_asym.pdbx_blank_PDB_chainid_flag N _struct_asym.pdbx_modified N _struct_asym.entity_id 1 _struct_asym.details ? # _struct_biol.id 1 # loop_ _struct_conf.conf_type_id _struct_conf.id _struct_conf.pdbx_PDB_helix_id _struct_conf.beg_label_comp_id _struct_conf.beg_label_asym_id _struct_conf.beg_label_seq_id _struct_conf.pdbx_beg_PDB_ins_code _struct_conf.end_label_comp_id _struct_conf.end_label_asym_id _struct_conf.end_label_seq_id _struct_conf.pdbx_end_PDB_ins_code _struct_conf.beg_auth_comp_id _struct_conf.beg_auth_asym_id _struct_conf.beg_auth_seq_id _struct_conf.end_auth_comp_id _struct_conf.end_auth_asym_id _struct_conf.end_auth_seq_id _struct_conf.pdbx_PDB_helix_class _struct_conf.details _struct_conf.pdbx_PDB_helix_length HELX_P HELX_P1 1 ALA A 2 ? ASP A 7 ? ALA A 2 ASP A 7 1 ? 6 HELX_P HELX_P2 2 ASP A 7 ? HIS A 13 ? ASP A 7 HIS A 13 1 ? 7 # _struct_conf_type.id HELX_P _struct_conf_type.criteria ? _struct_conf_type.reference ? # _database_PDB_matrix.entry_id 1O6N _database_PDB_matrix.origx[1][1] 1.000000 _database_PDB_matrix.origx[1][2] 0.000000 _database_PDB_matrix.origx[1][3] 0.000000 _database_PDB_matrix.origx[2][1] 0.000000 _database_PDB_matrix.origx[2][2] 1.000000 _database_PDB_matrix.origx[2][3] 0.000000 _database_PDB_matrix.origx[3][1] 0.000000 _database_PDB_matrix.origx[3][2] 0.000000 _database_PDB_matrix.origx[3][3] 1.000000 _database_PDB_matrix.origx_vector[1] 0.00000 _database_PDB_matrix.origx_vector[2] 0.00000 _database_PDB_matrix.origx_vector[3] 0.00000 # _atom_sites.entry_id 1O6N _atom_sites.fract_transf_matrix[1][1] 1.000000 _atom_sites.fract_transf_matrix[1][2] 0.000000 _atom_sites.fract_transf_matrix[1][3] 0.000000 _atom_sites.fract_transf_matrix[2][1] 0.000000 _atom_sites.fract_transf_matrix[2][2] 1.000000 _atom_sites.fract_transf_matrix[2][3] 0.000000 _atom_sites.fract_transf_matrix[3][1] 0.000000 _atom_sites.fract_transf_matrix[3][2] 0.000000 _atom_sites.fract_transf_matrix[3][3] 1.000000 _atom_sites.fract_transf_vector[1] 0.00000 _atom_sites.fract_transf_vector[2] 0.00000 _atom_sites.fract_transf_vector[3] 0.00000 # loop_ _atom_type.symbol C H N O # loop_ _pdbx_poly_seq_scheme.asym_id _pdbx_poly_seq_scheme.entity_id _pdbx_poly_seq_scheme.seq_id _pdbx_poly_seq_scheme.mon_id _pdbx_poly_seq_scheme.ndb_seq_num _pdbx_poly_seq_scheme.pdb_seq_num _pdbx_poly_seq_scheme.auth_seq_num _pdbx_poly_seq_scheme.pdb_mon_id _pdbx_poly_seq_scheme.auth_mon_id _pdbx_poly_seq_scheme.pdb_strand_id _pdbx_poly_seq_scheme.pdb_ins_code _pdbx_poly_seq_scheme.hetero A 1 1 ASP 1 1 1 ASP ASP A . n A 1 2 ALA 2 2 2 ALA ALA A . n A 1 3 GLU 3 3 3 GLU GLU A . n A 1 4 PHE 4 4 4 PHE PHE A . n A 1 5 ARG 5 5 5 ARG ARG A . n A 1 6 HIS 6 6 6 HIS HIS A . n A 1 7 ASP 7 7 7 ASP ASP A . n A 1 8 SER 8 8 8 SER SER A . n A 1 9 GLY 9 9 9 GLY GLY A . n A 1 10 TYR 10 10 10 TYR TYR A . n A 1 11 GLU 11 11 11 GLU GLU A . n A 1 12 VAL 12 12 12 VAL VAL A . n A 1 13 HIS 13 13 13 HIS HIS A . n A 1 14 HIS 14 14 14 HIS HIS A . n A 1 15 GLN 15 15 15 GLN GLN A . n A 1 16 LYS 16 16 16 LYS LYS A . n # _pdbx_struct_assembly.id 1 _pdbx_struct_assembly.details author_defined_assembly _pdbx_struct_assembly.method_details ? _pdbx_struct_assembly.oligomeric_details monomeric _pdbx_struct_assembly.oligomeric_count 1 # _pdbx_struct_assembly_gen.assembly_id 1 _pdbx_struct_assembly_gen.oper_expression 1 _pdbx_struct_assembly_gen.asym_id_list A # _pdbx_struct_oper_list.id 1 _pdbx_struct_oper_list.type 'identity operation' _pdbx_struct_oper_list.name 1_555 _pdbx_struct_oper_list.symmetry_operation x,y,z _pdbx_struct_oper_list.matrix[1][1] 1.0000000000 _pdbx_struct_oper_list.matrix[1][2] 0.0000000000 _pdbx_struct_oper_list.matrix[1][3] 0.0000000000 _pdbx_struct_oper_list.vector[1] 0.0000000000 _pdbx_struct_oper_list.matrix[2][1] 0.0000000000 _pdbx_struct_oper_list.matrix[2][2] 1.0000000000 _pdbx_struct_oper_list.matrix[2][3] 0.0000000000 _pdbx_struct_oper_list.vector[2] 0.0000000000 _pdbx_struct_oper_list.matrix[3][1] 0.0000000000 _pdbx_struct_oper_list.matrix[3][2] 0.0000000000 _pdbx_struct_oper_list.matrix[3][3] 1.0000000000 _pdbx_struct_oper_list.vector[3] 0.0000000000 # loop_ _pdbx_audit_revision_history.ordinal _pdbx_audit_revision_history.data_content_type _pdbx_audit_revision_history.major_revision _pdbx_audit_revision_history.minor_revision _pdbx_audit_revision_history.revision_date 1 'Structure model' 1 0 2002-11-07 2 'Structure model' 1 1 2005-04-21 # loop_ _pdbx_audit_revision_details.ordinal _pdbx_audit_revision_details.revision_ordinal _pdbx_audit_revision_details.data_content_type _pdbx_audit_revision_details.provider _pdbx_audit_revision_details.type _pdbx_audit_revision_details.description 1 1 'Structure model' repository 'Initial release' ? 2 2 'Structure model' repository Obsolete ? # _pdbx_entry_details.entry_id 1O6N _pdbx_entry_details.compound_details ;MAJOR COMPONENT OF EXTRACELLULAR AMYLOID PLAQUES AND VASCULAR AMYLOID DEPOSITS CHARACTERISTIC OF BOTH ALZHEIMER'S DISEASE (AD) AND AGED DOWN'S SYNDROME. ; _pdbx_entry_details.source_details ? _pdbx_entry_details.nonpolymer_details ? _pdbx_entry_details.sequence_details ? # loop_ _pdbx_validate_torsion.id _pdbx_validate_torsion.PDB_model_num _pdbx_validate_torsion.auth_comp_id _pdbx_validate_torsion.auth_asym_id _pdbx_validate_torsion.auth_seq_id _pdbx_validate_torsion.PDB_ins_code _pdbx_validate_torsion.label_alt_id _pdbx_validate_torsion.phi _pdbx_validate_torsion.psi 1 1 GLN A 15 ? ? 75.14 125.80 2 2 ASP A 7 ? ? -105.23 59.04 3 3 GLN A 15 ? ? 58.06 74.87 4 4 ALA A 2 ? ? -98.44 54.08 5 4 GLN A 15 ? ? 54.87 86.30 6 5 HIS A 14 ? ? -116.00 75.63 7 5 GLN A 15 ? ? 67.00 74.89 8 6 ALA A 2 ? ? -99.54 43.16 9 6 ASP A 7 ? ? -98.11 58.06 10 6 GLN A 15 ? ? 75.29 94.23 11 7 ASP A 7 ? ? -103.09 61.58 12 7 HIS A 14 ? ? -100.79 70.02 13 8 ALA A 2 ? ? -98.37 56.71 14 8 ASP A 7 ? ? -101.13 61.35 15 9 ALA A 2 ? ? -98.98 59.08 16 9 ASP A 7 ? ? -106.99 58.34 17 10 ALA A 2 ? ? -98.46 53.72 18 10 ASP A 7 ? ? -101.01 57.53 19 10 HIS A 14 ? ? -102.17 73.25 20 11 ALA A 2 ? ? -99.92 44.43 21 11 HIS A 14 ? ? -118.84 75.70 22 12 ALA A 2 ? ? -98.82 51.18 23 12 HIS A 14 ? ? -102.50 59.85 24 13 ALA A 2 ? ? -98.33 58.76 25 13 HIS A 14 ? ? -111.55 71.69 26 14 ALA A 2 ? ? -99.13 51.83 27 14 HIS A 14 ? ? -102.50 63.13 28 15 ASP A 7 ? ? -105.43 59.35 29 16 HIS A 14 ? ? -103.54 71.28 30 17 ALA A 2 ? ? -98.87 50.96 31 17 HIS A 14 ? ? -119.62 74.42 32 18 ASP A 7 ? ? -103.14 64.12 33 18 GLN A 15 ? ? 72.96 106.49 34 19 GLN A 15 ? ? 71.52 110.29 35 20 ALA A 2 ? ? -99.15 52.75 36 20 ASP A 7 ? ? -101.01 63.03 37 20 HIS A 14 ? ? -111.44 68.88 38 21 ALA A 2 ? ? -99.48 46.84 39 21 HIS A 14 ? ? -102.35 69.28 40 22 ALA A 2 ? ? -99.16 44.19 41 22 SER A 8 ? ? -92.65 -61.48 42 22 HIS A 13 ? ? -111.91 65.03 43 22 GLN A 15 ? ? 63.91 63.99 44 23 ALA A 2 ? ? -99.02 57.16 45 23 HIS A 14 ? ? -117.37 70.36 46 24 ALA A 2 ? ? -98.62 57.30 47 24 SER A 8 ? ? -92.74 -68.99 48 24 HIS A 14 ? ? -116.27 74.52 49 24 GLN A 15 ? ? 67.38 82.07 50 25 GLN A 15 ? ? 60.90 84.13 51 26 ALA A 2 ? ? -98.57 54.32 52 26 SER A 8 ? ? -91.14 -66.63 53 27 ALA A 2 ? ? -100.18 48.26 54 27 HIS A 13 ? ? -97.85 41.92 55 28 ALA A 2 ? ? -99.37 48.86 56 28 HIS A 14 ? ? -114.33 69.07 57 28 GLN A 15 ? ? 70.33 108.98 58 29 ALA A 2 ? ? -99.50 44.81 59 29 SER A 8 ? ? -92.05 -60.96 60 29 HIS A 14 ? ? -113.72 62.21 61 30 ALA A 2 ? ? -98.98 52.65 62 30 HIS A 14 ? ? -102.55 60.71 63 30 GLN A 15 ? ? 39.66 72.33 #